News
The agency is changing the standard of evidence required for Covid-19 vaccine approval in the US, Dr. Vinay Prasad, the new ...
The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...
The FDA recommended different standards of evidence for approval based on patients' risk of getting severely sick from Covid.
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...
COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift ...
FDA Commissioner Marty Makary and top U.S. vaccines regulator Vinay Prasad said based on data from tests that measure immune ...
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from ...
Currently, more than 300 million people are diagnosed with hepatitis around the world, according to the World Hepatitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results